Dayton Lab: Non-Invasive Functional Imaging and Targeted Therapeutics
Paul Dayton
Dayton group develops new technologies for imaging blood flow, microvasculature and molecular markers. Recent contributions to the field include advances in ultrasound-mediated therapeutics with micro and nanoparticles, and developing and applying tools for non-invasive assessment of angiogenesis progression and tumor response to therapy.